LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy

Endocrine-Related Cancer

Volumn 21, Issue 1, 2014, Pages 101-112

  Nagelkerke, Anika ^a   Sieuwerts, Anieta M ^b   Bussink, Johan ^a   Sweep, Fred C G J ^a   Look, Maxime P ^b   Foekens, John A ^b   Martens, John W M ^b   Span, Paul N ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MC CANCER INSTITUTE   (Netherlands)

Author keywords

Breast; Estrogen receptor; SERM

Indexed keywords

AFIMOXIFENE; CYCLOPHOSPHAMIDE; DENDRITIC CELL LYSOSOME ASSOCIATED MEMBRANE PROTEIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; MESSENGER RNA; METHOTREXATE; PROTEIN P62; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CELL STRAIN MCF 7; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG SENSITIZATION; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MAJOR CLINICAL STUDY; MIDDLE AGED; MODULATION; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION;

BREAST; ESTROGEN RECEPTOR; SERM;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; AUTOPHAGY; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, MESSENGER; TAMOXIFEN;

EID: 84893596560     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0183     Document Type: Article

References (46)

1. van Agthoven T, Sieuwerts AM, Meijer-van Gelder ME, Look MP, Smid M, Veldscholte J, Sleijfer S, Foekens JA & Dorssers LC 2009 Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance. Journal of Clinical Oncology 27 542-549. (doi:10.1200/JCO.2008.17.1462)
2. van Agthoven T, Sieuwerts AM, Meijer D, Meijer-van Gelder ME, van Agthoven TL, Sarwari R, Sleijfer S, Foekens JA & Dorssers LC 2010 Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response. Endocrine-Related Cancer 17 215-230. (doi:10.1677/ERC-09-0062)
3. Al-Rawashdeh FY, Scriven P, Cameron IC, Vergani PV & Wyld L 2010 Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 22 1099-1105. (doi:10.1097/MEG.0b013e3283378405)
4. Altman DG, McShane LM, Sauerbrei W & Taube SE 2012 Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. PLoS Medicine 9 e1001216. (doi:10.1371/journal.pmed.1001216)
5. Andrejewski N, Punnonen EL, Guhde G, Tanaka Y, Lullmann-Rauch R, Hartmann D, von Figura K & Saftig P 1999 Normal lysosomal morphology and function in LAMP-1-deficient mice. Journal of Biological Chemistry 274 12692-12701. (doi:10.1074/jbc.274.18.12692)
6. Bursch W, Ellinger A, Kienzl H, Torok L, Pandey S, Sikorska M, Walker R & Hermann RS 1996 Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17 1595-1607. (doi:10.1093/carcin/17.8.1595)
7. Chen R, Dai RY, Duan CY, Liu YP, Chen SK, Yan DM, Chen CN, Wei M & Li H 2011 Unfolded protein response suppresses cisplatin-induced apoptosis via autophagy regulation in human hepatocellular carcinoma cells. Folia Biologica 57 87-95.
8. Cole MP, Jones CT & Todd ID 1971 A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. British Journal of Cancer 25 270-275. (doi:10.1038/bjc.1971.33)
9. Cook KL, Shajahan AN, Warri A, Jin L, Hilakivi-Clarke LA & Clarke R 2012 Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen responsiveness. Cancer Research 72 3337-3349. (doi:10.1158/0008-5472.CAN-12-0269)
10. Duan L, Motchoulski N, Danzer B, Davidovich I, Shariat-Madar Z & Levenson VV 2011 Prolylcarboxypeptidase regulates proliferation, autophagy, and resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen receptor-positive breast cancer cells. Journal of Biological Chemistry 286 2864-2876. (doi:10.1074/jbc.M110.143271)
11. Eskelinen EL, Illert AL, Tanaka Y, Schwarzmann G, Blanz J, Von Figura K & Saftig P 2002 Role of LAMP-2 in lysosome biogenesis and autophagy. Molecular Biology of the Cell 13 3355-3368. (doi:10.1091/mbc.E02-02-0114)
12. Eskelinen EL, Tanaka Y & Saftig P 2003 At the acidic edge: emerging functions for lysosomal membrane proteins. Trends in Cell Biology 13 137-145. (doi:10.1016/S0962-8924(03)00005-9)
13. Fehrenbacher N, Bastholm L, Kirkegaard-Sorensen T, Rafn B, Bottzauw T, Nielsen C, Weber E, Shirasawa S, Kallunki T & Jaattela M 2008 Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Cancer Research 68 6623-6633. (doi:10.1158/0008-5472.CAN-08-0463)
14. Feldman DE, Chauhan V & Koong AC 2005 The unfolded protein response: a novel component of the hypoxic stress response in tumors. Molecular Cancer Research 3 597-605. (doi:10.1158/1541-7786.MCR-05-0221)
15. Foekens JA, Portengen H, van Putten WL, Peters HA, Krijnen HL, Alexieva-Figusch J & Klijn JG 1989 Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Cancer Research 49 5823-5828.
16. Giuliano M, Schifp R, Osborne CK & Trivedi MV 2011 Biological mechanisms and clinical implications of endocrine resistance in breast cancer. Breast 20 (Suppl 3) S42-S49. (doi:10.1016/S0960-9776(11)70293-4)
17. Gomez BP, Riggins RB, Shajahan AN, Klimach U, Wang A, Crawford AC, Zhu Y, Zwart A, Wang M & Clarke R 2007 Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB Journal 21 4013-4027. (doi:10.1096/fj.06-7990com)
18. Hayward JL, Carbone PP, Heuson JC, Kumaoka S, Segaloff A & Rubens RD 1977 Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. Cancer 39 1289-1294. (doi:10.1002/1097-0142(197703)39: 3<1289::AID-CNCR2820390340>3.0.CO;2-F)
19. Hippert MM, O'Toole PS & Thorburn A 2006 Autophagy in cancer: good, bad, or both? Cancer Research 66 9349-9351. (doi:10.1158/0008-5472.CAN-06-1597)
20. Igarashi T, Izumi H, Uchiumi T, Nishio K, Arao T, Tanabe M, Uramoto H, Sugio K, Yasumoto K, Sasaguri Y et al. 2007 Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene 26 4749-4760. (doi:10.1038/sj.onc.1210289)
21. John S, Nayvelt I, Hsu HC, Yang P, Liu W, Das GM, Thomas T & Thomas TJ 2008 Regulation of estrogenic effects by beclin 1 in breast cancer cells. Cancer Research 68 7855-7863. (doi:10.1158/0008-5472.CAN-07-5875)
22. Klionsky DJ & Emr SD 2000 Autophagy as a regulated pathway of cellular degradation. Science 290 1717-1721. (doi:10.1126/science. 290.5497.1717)
23. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A et al. 2008 Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4 151-175.
24. Maass H, Jonat W, Stolzenbach G & Trams G 1980 The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer. Cancer 46 2835-2837. (doi:10.1002/1097-0142(19801215)46:12+<2835::AID- CNCR2820461420>3.0.CO;2-M)
25. Mathew R & White E 2011 Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Current Opinion in Genetics & Development 21 113-119. (doi:10.1016/j.gde.2010.12.008)
26. Mazure NM & Pouyssegur J 2010 Hypoxia-induced autophagy: cell death or cell survival? Current Opinion in Cell Biology 22 177-180. (doi:10.1016/j.ceb.2009.11.015)
27. Milani M, Rzymski T, Mellor HR, Pike L, Bottini A, Generali D & Harris AL 2009 The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Research 69 4415-4423. (doi:10.1158/0008-5472.CAN-08-2839)
28. Mizushima N, Yoshimori T & Levine B 2010 Methods in mammalian autophagy research. Cell 140 313-326. (doi:10.1016/j.cell.2010.01.028)
29. Mujcic H, Rzymski T, Rouschop KM, Koritzinsky M, Milani M, Harris AL & Wouters BG 2009 Hypoxic activation of the unfolded protein response (UPR) induces expression of themetastasis-associated gene LAMP3. Radiotherapy and Oncology 92 450-459. (doi:10.1016/j.radonc.2009.08.017)
30. Nagelkerke A, Mujcic H, Bussink J, Wouters BG, van Laarhoven HW, Sweep FC & Span PN 2011 Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer. Cancer 117 3670-3681. (doi:10.1002/cncr.25938)
31. Nagelkerke A, Bussink J, Mujcic H, Wouters BG, Lehmann S, Sweep FC & Span PN 2013a Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response. Breast Cancer Research 15 R2. (doi:10.1186/bcr3373)
32. Nagelkerke A, Bussink J, van der Kogel AJ, Sweep FC & Span PN 2013b The PERK/ATF4/LAMP3-arm of the unfolded protein response affects radioresistance by interfering with the DNA damage response. Radiotherapy and Oncology 108 415-421. (doi:10.1016/j.radonc.2013.06.037)
33. Namgoong GM, Khanal P, Cho HG, Lim SC, Oh YK, Kang BS, Shim JH, Yoo JC & Choi HS 2010 The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer. Journal of Biological Chemistry 285 23829-23841. (doi:10.1074/jbc.M109.092874)
34. Osborne CK 1998 Tamoxifen in the treatment of breast cancer. New England Journal of Medicine 339 1609-1618. (doi:10.1056/NEJM199811263392207)
35. Osborne CK, Yochmowitz MG, Knight WA III & McGuire WL 1980 The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46 2884-2888. (doi:10.1002/1097-0142(19801215)46:12+<2884::AID- CNCR2820461429>3.0.CO;2-U)
36. Pyrko P, Schonthal AH, Hofman FM, Chen TC & Lee AS 2007 The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Research 67 9809-9816. (doi:10.1158/0008-5472.CAN-07-0625)
37. Qadir MA, Kwok B, Dragowska WH, To KH, Le D, Bally MB & Gorski SM 2008 Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Research and Treatment 112 389-403. (doi:10.1007/s10549-007-9873-4)
38. Riggs BL & Hartmann LC 2003 Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. New England Journal of Medicine 348 618-629. (doi:10.1056/NEJMra022219)
39. Rouschop KM, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW et al. 2010 The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. Journal of Clinical Investigation 120 127-141. (doi:10.1172/JCI40027)
40. Rzymski T, Milani M, Pike L, Buffa F, Mellor HR, Winchester L, Pires I, Hammond E, Ragoussis I & Harris AL 2010 Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene 29 4424-4435. (doi:10.1038/onc.2010.191)
41. Samaddar JS, Gaddy VT, Duplantier J, Thandavan SP, Shah M, Smith MJ, Browning D, Rawson J, Smith SB, Barrett JT et al. 2008 A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance. Molecular Cancer Therapeutics 7 2977-2987. (doi:10.1158/1535-7163.MCT-08-0447)
42. Scriven P, Coulson S, Haines R, Balasubramanian S, Cross S & Wyld L 2009 Activation and clinical significance of the unfolded protein response in breast cancer. British Journal of Cancer 101 1692-1698. (doi:10.1038/sj.bjc. 6605365)
43. Sieuwerts AM, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, Arnold M, Goedheer AJ, Portengen H, Klijn JG & Foekens JA 2005 How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study. Clinical Cancer Research 11 7311-7321. (doi:10.1158/1078-0432.CCR-05-0560)
44. Tanabe M, Izumi H, Ise T, Higuchi S, Yamori T, Yasumoto K & Kohno K 2003 Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines. Cancer Research 63 8592-8595.
45. Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lullmann-Rauch R, Janssen PM, Blanz J, von Figura K & Saftig P 2000 Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406 902-906. (doi:10.1038/35022595)
46. Wouters BG & Koritzinsky M 2008 Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nature Reviews. Cancer 8 851-864. (doi:10.1038/nrc2501)